Karen N McFarland Selected Research

Ataxin-10

1/2017	Inheritance patterns of ATCCT repeat interruptions in spinocerebellar ataxia type 10 (SCA10) expansions.
3/2014	Repeat interruptions in spinocerebellar ataxia type 10 expansions are strongly associated with epileptic seizures.
1/2013	Expansion of the Spinocerebellar ataxia type 10 (SCA10) repeat in a patient with Sioux Native American ancestry.
9/2012	Transgenic models of spinocerebellar ataxia type 10: modeling a repeat expansion disorder.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Karen N McFarland Research Topics

Disease

5	Spinocerebellar Ataxia 10 01/2017 - 09/2012
3	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 01/2021
3	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2019 - 10/2008
3	Spinocerebellar Ataxias (Spinocerebellar Ataxia) 01/2017 - 01/2013
3	Huntington Disease (Huntington's Disease) 01/2013 - 10/2008
2	Amyloid Plaque 01/2022 - 01/2019
2	Neuroinflammatory Diseases 01/2022 - 03/2021
2	Parkinson Disease (Parkinson's Disease) 03/2021 - 01/2019
2	Cerebellar Ataxia (Dysmetria) 01/2017 - 01/2013
1	Synucleinopathies 03/2021
1	Proteostasis Deficiencies 03/2021
1	Gliosis 01/2021
1	Cerebral Amyloid Angiopathy (Congophilic Angiopathy) 12/2020
1	Lewy Body Disease (Lewy Body Dementia) 01/2019
1	Epilepsy (Aura) 01/2017
1	Parkinsonian Disorders (Parkinsonism) 01/2017
1	Strabismus (Squint) 06/2005

Drug/Important Bio-Agent (IBA)

4	Ataxin-10IBA 01/2017 - 09/2012
3	Amyloid (Amyloid Fibrils)IBA 01/2022 - 01/2021
2	Proteins (Proteins, Gene)FDA Link 01/2019 - 10/2008
2	PENTAIBA 01/2017 - 03/2014
2	Histones (Histone)IBA 01/2013 - 01/2012
1	ProteomeIBA 01/2022
1	Interleukin-10 (Interleukin 10)IBA 03/2021
1	Amyloid beta-PeptidesIBA 12/2020
1	AntibodiesIBA 01/2019
1	SynucleinsIBA 01/2019
1	Levodopa (L Dopa)FDA LinkGeneric 01/2017
1	NucleotidesIBA 01/2015
1	polyglutamineIBA 10/2008
1	Minocycline (Cyclops)FDA LinkGeneric 06/2005

Therapy/Procedure

3	Therapeutics 01/2022 - 01/2021
1	Immunotherapy 01/2021